'Co-conspirator' cells could hold key to melanoma prediction, prevention

August 30, 2010

New research on how skin cancer begins has identified adjacent cancer cells that scientists are calling "co-conspirators" in the genesis of melanoma, in findings that could someday hold the key to predicting, preventing and stopping this hard-to-treat cancer before it spreads.

Changes in the body's pigment-producing cells, where - the most dangerous form of - takes hold are only part of the story, according to a new study by researchers from Oregon State University.

Other skin cells in what's called the "microenvironment" of the cancer site also play a key role, scientists say.

"These adjacent cells, which are called keratinocytes, are actually the driver for the changes and malignant transformation in the pigment-producing cells, which are called melanocytes," said Arup Indra, an assistant professor in the OSU College of Pharmacy.

"So there are two avenues - the pigment-producing cells where the cancer develops, and the adjacent skin cells which 'talk to' the pigment-producing cells in the form of signals," Indra said. "They work in coordination, they are partners in crime."

Research was done with both animal models and human samples, from individuals who carry a mutation in a gene called Cdk4, which is an inherited predisposition to melanoma that has turned up in families in Norway, France, Australia and England.

The study found that a protein called RXR-alpha in skin keratinocytes appears to protect from damage, and prevent them from progressing to invasive melanoma.

This protein in skin cells sends to the adjacent pigment cells, Indra said. The study revealed that these signals can, in effect, prevent or block the abnormal proliferation of pigment-producing cells in laboratory mice. Conversely, when the protein was removed or repressed, melanoma cells became aggressive and invaded the animals' lymph nodes.

However, both the protective protein and pigment cells can suffer damage from chemical toxins or ultraviolet sunlight in the pigment cells, creating a "double-edged sword" in melanoma's complex etiology, according to Indra.

To study melanoma cells in isolation from their surrounding biochemical and molecular environment is to miss the intricate series of related interactions that give rise to the disease, he said.

The finding could lead to promising new prevention tools down the road, Indra said.

"Better understanding this process will help us design new and novel strategies for prevention and, possibly, a cure," Indra said. "This could be a predictive prognostic tool for discovering melanoma predisposition in humans. And that could lead to better and earlier diagnostics."

More information: This study was featured on the current cover of the journal Pigment Cell and Melanoma Research.

Related Stories

Recommended for you

CAR-T immunotherapy may help blood cancer patients who don't respond to standard treatments

October 20, 2017
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is one of the first centers nationwide to offer a new immunotherapy that targets certain blood cancers. Newly approved ...

Researchers pinpoint causes for spike in breast cancer genetic testing

October 20, 2017
A sharp rise in the number of women seeking BRCA genetic testing to evaluate their risk of developing breast cancer was driven by multiple factors, including celebrity endorsement, according to researchers at the University ...

Study shows how nerves drive prostate cancer

October 19, 2017
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels ...

Gene circuit switches on inside cancer cells, triggers immune attack

October 19, 2017
Researchers at MIT have developed a synthetic gene circuit that triggers the body's immune system to attack cancers when it detects signs of the disease.

One to 10 mutations are needed to drive cancer, scientists find

October 19, 2017
For the first time, scientists have provided unbiased estimates of the number of mutations needed for cancers to develop, in a study of more than 7,500 tumours across 29 cancer types. Researchers from the Wellcome Trust Sanger ...

Suicide molecules kill any cancer cell

October 19, 2017
Small RNA molecules originally developed as a tool to study gene function trigger a mechanism hidden in every cell that forces the cell to commit suicide, reports a new Northwestern Medicine study, the first to identify molecules ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.